CHARENTON-LE-PONT, France, June 16 /PRNewswire-FirstCall/ -- Essilor and the Swiss company Schweiter Technologies AG announced today that they have signed a share purchase agreement whereby Essilor will offer to acquire the shares of Schweiter subsidiary Satisloh Holding AG. The agreement is subject to certain conditions precedent, including approval by competition authorities in Satisloh's main host countries. The acquisition could be completed in the second half of the year.
Created by the merger of Satis and Loh in 2004, Satisloh has a global distribution network and is the world's leading supplier of prescription laboratory equipment. It manufactures and markets antireflective coating units and surfacing machines, as well as consumables. The company reported revenues of EUR161 million in 2007 and has more than 400 employees. Led by the same management team and based in its current locations, Satisloh will continue to develop innovative solutions for all its customers.
In the future, the combination of Essilor and Satisloh's research
capabilities and expertise will make it possible to offer all industry
participants a broader, more competitive range of products and services,
while shortening time to market cycles for new production processes. For
Essilor, the acquisition not only opens up a new area of business, it also
offers a strong fit with the Company's strategy of innovation and the
development of services for prescription laboratories, optical chains and
eye care professionals around the world.
A conference call in English will be held today, at 10:00 am
The number to dial is: +33(0)1-70-99-42-79.
The number to dial for replay from June 16th to June 18th will be
+33(0)1-71-23-02-48 - Access code: 6662941#.
The conference will also be available at
http://www.essilor.com/Satisloh-Acquisition from June 17th.
Essilor International is the world leader in ophthalmic optical
products, offering a wide range of lenses under the flagship Varilux(R),
Crizal(R), Essilor(R) and Definity(R) brands to correct myopia, hyperopia,
presbyopia and astigmatism. Essilor operates worldwide through 15
production sites, 270 lens finishing laboratories and local distribution
networks. The Essilor share trades on the Euronext Paris market and is
included in the CAC 40 index. (ISIN: FR 0000121667; Reuters: ESSI.PA;
Bloomberg: EF FP).
Investor Relations and Financial Communications
Véronique Gillet - Sébastien Leroy
Copyright©2008 PR Newswire.
All rights reserved